Healthcare Services company Vijaya Diagnostic Centre announced Q3FY25 results Revenue from Operations: Rs 1,689.8 million compared to Rs 1,326.9 million during Q3FY24, change 27.3%. EBITDA: Rs 671.3 million compared to Rs 523.1 million during Q3FY24, change 28.3%. EBITDA margin: 39.7% for Q3FY25. PAT: Rs 351.6 million compared to Rs 258.5 million during Q3FY24, change 36.0%. PAT margin: 20.8% for Q3FY25. Suprita Reddy, MD & CEO said: “I’m pleased to announce another strong quarter, marked by a remarkable year-on-year revenue growth of 27.3%, with a solid 20.2% growth achieved organically. This strong performance was primarily driven by volume across both Pathology and Radiology segments. I am happy to share that we have operationalized our 1st centre at Pimple Saudagar, Pune (Spoke) under Vijaya PH Brand in this month, following the PH acquisition. Looking ahead, I am excited to announce that we would be commissioning 6 hubs across Pune, West Bengal and Bengaluru in the coming 3 months, taking our total hub addition to 9 in the 12-month period which marks a significant milestone in the history of Vijaya. We have also made key strategic hires at the mid and senior levels across functions to support the management in driving the next phase of growth.” Result PDF